This site is intended for healthcare professionals

Novinky z tohtoročného najvýznamnejšieho stretnutia onkológov 2017

Risk-Based Approach to Chemotherapy Duration Recommended for Stage III Colon Cancer

Tim Donald

Novinky z tohtoročného najvýznamnejšieho stretnutia onkológov 2017

June 4, 2017   effective as a standard 6-month course—with a difference in disease-free survival (DFS) of less than 1%—while reducing the risk of neurotoxicity and other adverse events. A subgroup analysis further showed that the 3-month course was most appropriate for low-risk patients (Abstract LBA1). In view of these findings, investigators in the IDEA...

Zpět

Cystická fibróza 1/2025

07 | 07 | 2025

Antiinfectives News 1/2025

30 | 06 | 2025

Paediatric News 1/2025

04 | 04 | 2025

Už čoskoro vyjde nové číslo časopisu Paediatric News.




Partneři projektu